Developer docs
API playgroundTry for free, no card

Search company profiles

Michelson Diagnostics

Full company profile

uuid0009ios

Namestring
Michelson Diagnostics
Legal namestring
Nobel Medical LLC
Websiteurl
md-ltd.co.uk
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Michelson Diagnostics is a privately-held UK medical device company founded in 2006, headquartered in Orpington, United Kingdom, that develops and manufactures products based on multi-beam Optical Coherence Tomography (OCT) technology. The company employs between 11 and 50 people and operates through its corporate website at md-ltd.co.uk. Its corporate registration and operating geography are in the United Kingdom, and it remains a private, non-listed entity.

The company's core technology is multi-beam Optical Coherence Tomography, an advanced optical imaging modality that enables high-resolution, non-invasive imaging of tissue structures. This positions Michelson Diagnostics in the medical imaging device sector, with applications in clinical diagnostics where non-invasive visualization is clinically valuable. The company has been operating in this specialised niche since its founding in 2006.

Michelson Diagnostics has historically funded its operations through equity financings, raising approximately $10.8 million in aggregate across multiple rounds between 2007 and 2015. Key institutional investors have included Octopus Ventures (lead investor on multiple rounds), Catapult Ventures, and Newable Private Investing, alongside strategic investor Smith & Nephew — a global medical device manufacturer — and angel investor group Angels 5K. The company has not disclosed any subsequent funding activity, leadership changes, acquisitions, product launches, or geographic expansions in the available source material, leaving a significant information gap regarding post-2015 developments.

Short descriptiontext

Michelson Diagnostics is a UK-based medical device company founded in 2006 that develops and manufactures multi-beam Optical Coherence Tomography (OCT) imaging products for clinical diagnostics, with a workforce of 11-50 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersOrpington, United Kingdom
HQ citystring
Orpington
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
optical coherence tomography, medical imaging devices, diagnostic imaging equipment, OCT imaging systems, medical diagnostic instruments
Industry2 codes
1Microscopy, Imaging & Flow Cytometry Instruments
CodeHLAGAIAEPrimaryYes
2Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography)
CodeHLAHAJABPrimaryNo
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Optical Instruments & Lenses3827
Product category
Medical Imaging Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Certificate Issuance
TypeOne Time License
Description

One-time fee per certificate issued. Customer pays upfront at time of application. Full refund provided if the GP cannot issue a certificate. Over 30 certificate types available at varying price points starting from £39.

medicalcert.co.uk
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Standard medical certificates from £39
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Starting price from £39. Full automatic refund if the reviewing GP determines a certificate cannot be issued on clinical grounds. Price varies by certificate type and complexity of clinical review.

medicalcert.co.uk
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography (OCT)-based products for medical diagnostic imaging. The company designs and produces imaging systems that leverage proprietary multi-beam OCT technology, operating as a medical device manufacturer headquartered in Orpington, United Kingdom. Founded in 2006, the firm supplies OCT-based imaging products to clinical and research customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Most certificates reviewed and issued same day
+1 more record
Product overview1 text field

MedicalCert is a digital marketplace connecting patients with independent UK GMC-registered doctors for private medical certificate consultations. The service operates as a unified online platform where patients complete a medical questionnaire, submit supporting evidence, and receive individual clinical review from a GMC-registered doctor. The platform offers over 30 distinct certificate types including sick notes, fit-to-work certificates, mental health certificates, travel certificates (fit-to-fly, cruise, cancellation), sports certificates, education certificates, housing support letters, and custom medical documentation. Each certificate is individually drafted by the reviewing GP and delivered as a signed, verifiable PDF. Key differentiator is no appointment required, same-day or next-morning delivery, and full refund if the GP cannot issue.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MedicalCert partners with NHS Doctors for clinical service delivery. All doctors hold GMC registration and NHS clinical experience. This partnership provides the clinical workforce for the platform's certificate review services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Established imaging device company best known for ophthalmic OCT (Spectralis), with broader clinical imaging presence. Comparable as a medical OCT manufacturer with a deep installed base, though focused on ophthalmology rather than dermatology.

TypeBroad incumbent
Description

Ophthalmic OCT and multimodal imaging vendor now part of Visionix/Bonet Group. Comparable as a medical OCT specialist with strong installed base, although focused on ophthalmic indications.

TypeBroad incumbent
Description

Major ophthalmic and medical imaging company producing OCT instruments and multimodal diagnostic platforms. Comparable as a large-scale medical imaging device manufacturer with overlapping OCT technology.

TypeEmerging player
Description

Supplies OCT systems and OEM optical components for both research and clinical imaging, including skin/dermatology applications. Comparable as an OCT instrumentation provider with overlapping technology base and customer profile in research dermatology.

TypeEmerging player
Description

Developer of OCT systems and components for clinical and research imaging, including dermatology, ophthalmology, and industrial inspection. Comparable as a multi-beam OCT specialist with adjacent technical positioning.

TypeBroad incumbent
Description

Global medical technology incumbent with broad ophthalmic and surgical microscopy offerings including OCT platforms. Comparable as a dominant medical imaging device OEM that could expand into dermatology/wound-care imaging.

TypeDirect peer
Description

German developer of clinical and research OCT systems, including dedicated skin and dermatology OCT platforms. Closest functional peer to Michelson Diagnostics in dermatology OCT, competing in the same clinical indications and end-user specialty clinics.

TypeDirect peer
Description

Through the Caliber I.D. / VivaScope product line, MAVIG offers in-vivo confocal and multimodal skin imaging used in dermatology. Overlaps with Michelson in non-invasive dermatology imaging use cases and clinical dermatology end users.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Michelson Diagnostics

Medical Imaging Equipmentmd-ltd.co.uk

Michelson Diagnostics is a UK-based medical device company founded in 2006 that develops and manufactures multi-beam Optical Coherence Tomography (OCT) imaging products for clinical diagnostics, with a workforce of 11-50 employees.

What Michelson Diagnostics does

Michelson Diagnostics is a privately-held UK medical device company founded in 2006, headquartered in Orpington, United Kingdom, that develops and manufactures products based on multi-beam Optical Coherence Tomography (OCT) technology. The company employs between 11 and 50 people and operates through its corporate website at md-ltd.co.uk. Its corporate registration and operating geography are in the United Kingdom, and it remains a private, non-listed entity.

The company's core technology is multi-beam Optical Coherence Tomography, an advanced optical imaging modality that enables high-resolution, non-invasive imaging of tissue structures. This positions Michelson Diagnostics in the medical imaging device sector, with applications in clinical diagnostics where non-invasive visualization is clinically valuable. The company has been operating in this specialised niche since its founding in 2006.

Michelson Diagnostics has historically funded its operations through equity financings, raising approximately $10.8 million in aggregate across multiple rounds between 2007 and 2015. Key institutional investors have included Octopus Ventures (lead investor on multiple rounds), Catapult Ventures, and Newable Private Investing, alongside strategic investor Smith & Nephew — a global medical device manufacturer — and angel investor group Angels 5K. The company has not disclosed any subsequent funding activity, leadership changes, acquisitions, product launches, or geographic expansions in the available source material, leaving a significant information gap regarding post-2015 developments.

Michelson Diagnostics firmographics

Firmographics
Name
Michelson Diagnostics
Legal name
Nobel Medical LLC
Website
https://md-ltd.co.uk
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
11–50 employees
Short description
Michelson Diagnostics is a UK-based medical device company founded in 2006 that develops and manufactures multi-beam Optical Coherence Tomography (OCT) imaging products for clinical diagnostics, with a workforce of 11-50 employees.
Ownership category
akta.pro rank

Michelson Diagnostics industry classification

Industry
Product category
Medical Imaging Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)
akta.pro primary industry
Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
akta.pro secondary industry
Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography) (HLAHAJAB)

Keywords

  • Optical coherence tomography
  • Medical imaging devices
  • Diagnostic imaging equipment
  • OCT imaging systems
  • Medical diagnostic instruments

Where Michelson Diagnostics is headquartered

Location

Headquarters

HQ city
Orpington
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Michelson Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

  1. Medical Certificate Issuance: One-time fee per certificate issued. Customer pays upfront at time of application. Full refund provided if the GP cannot issue a certificate. Over 30 certificate types available at varying price points starting from £39.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goStandard medical certificates from £39

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Michelson Diagnostics product offering

Product offering

Core offering

Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography (OCT)-based products for medical diagnostic imaging. The company designs and produces imaging systems that leverage proprietary multi-beam OCT technology, operating as a medical device manufacturer headquartered in Orpington, United Kingdom. Founded in 2006, the firm supplies OCT-based imaging products to clinical and research customers.

Product overview

MedicalCert is a digital marketplace connecting patients with independent UK GMC-registered doctors for private medical certificate consultations. The service operates as a unified online platform where patients complete a medical questionnaire, submit supporting evidence, and receive individual clinical review from a GMC-registered doctor. The platform offers over 30 distinct certificate types including sick notes, fit-to-work certificates, mental health certificates, travel certificates (fit-to-fly, cruise, cancellation), sports certificates, education certificates, housing support letters, and custom medical documentation. Each certificate is individually drafted by the reviewing GP and delivered as a signed, verifiable PDF. Key differentiator is no appointment required, same-day or next-morning delivery, and full refund if the GP cannot issue.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Most certificates reviewed and issued same day
  • +1 more outcomes

Companies that use Michelson Diagnostics

Customer profile

Named customers1 record

Segments5 records

Ideal customer profiles1 record

Michelson Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Michelson Diagnostics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NHS DoctorscoreStrategic or Co-development PartnerMedicalCert partners with NHS Doctors for clinical service delivery. All doctors hold GMC registration and NHS clinical experience. This partnership provides the clinical workforce for the platform's certificate review services.

Scale indicators3 records

Recent moves6 records

Expansion highlights2 records

Michelson Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Heidelberg Engineering: Established imaging device company best known for ophthalmic OCT (Spectralis), with broader clinical imaging presence. Comparable as a medical OCT manufacturer with a deep installed base, though focused on ophthalmology rather than dermatology.
  • Optovue (Visionix): Ophthalmic OCT and multimodal imaging vendor now part of Visionix/Bonet Group. Comparable as a medical OCT specialist with strong installed base, although focused on ophthalmic indications.
  • TOPCON Healthcare: Major ophthalmic and medical imaging company producing OCT instruments and multimodal diagnostic platforms. Comparable as a large-scale medical imaging device manufacturer with overlapping OCT technology.
  • Carl Zeiss Meditec: Global medical technology incumbent with broad ophthalmic and surgical microscopy offerings including OCT platforms. Comparable as a dominant medical imaging device OEM that could expand into dermatology/wound-care imaging.

Emerging players

  • Thorlabs: Supplies OCT systems and OEM optical components for both research and clinical imaging, including skin/dermatology applications. Comparable as an OCT instrumentation provider with overlapping technology base and customer profile in research dermatology.
  • Wasatch Photonics: Developer of OCT systems and components for clinical and research imaging, including dermatology, ophthalmology, and industrial inspection. Comparable as a multi-beam OCT specialist with adjacent technical positioning.

Direct peers

  • Jenlab GmbH: German developer of clinical and research OCT systems, including dedicated skin and dermatology OCT platforms. Closest functional peer to Michelson Diagnostics in dermatology OCT, competing in the same clinical indications and end-user specialty clinics.
  • MAVIG (formerly Caliber I.D.): Through the Caliber I.D. / VivaScope product line, MAVIG offers in-vivo confocal and multimodal skin imaging used in dermatology. Overlaps with Michelson in non-invasive dermatology imaging use cases and clinical dermatology end users.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Michelson Diagnostics social profiles

Digital presence

Michelson Diagnostics compliance and trust

Trust signal

Compliance2 records

Michelson Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Michelson Diagnostics leadership team

Management profile

Number of profiles

Profiles4 records

Michelson Diagnostics funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Michelson Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Michelson Diagnostics

What does Michelson Diagnostics do?

Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography (OCT)-based products for medical diagnostic imaging. The company designs and produces imaging systems that leverage proprietary multi-beam OCT technology, operating as a medical device manufacturer headquartered in Orpington, United Kingdom. Founded in 2006, the firm supplies OCT-based imaging products to clinical and research customers.

Is Michelson Diagnostics a public or private company?

Michelson Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Michelson Diagnostics founded?

Michelson Diagnostics was founded in 2006. It employs 11 to 50 people.

Where is Michelson Diagnostics based?

Michelson Diagnostics is headquartered in Orpington, United Kingdom, in the Europe region.

How does Michelson Diagnostics make money?

One revenue line is on record: medical Certificate Issuance.

Who are Michelson Diagnostics's main competitors?

Broad incumbents on record are Heidelberg Engineering, Optovue (Visionix), TOPCON Healthcare and Carl Zeiss Meditec. Emerging players are Thorlabs and Wasatch Photonics. Direct peers are Jenlab GmbH and MAVIG (formerly Caliber I.D.).

Does Michelson Diagnostics have an API?

No public API is recorded for Michelson Diagnostics.

What industry is Michelson Diagnostics in?

Michelson Diagnostics's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHAJAB, Retinal Imaging & OCT Systems (OCT/OCTA, Fundus Cameras, Fluorescein/ICG Angiography). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire66% of diagnostic biopsies for common skin cancer can be avoided using Michelson Diagnostics' VivoSight OCT laser scannerA major randomized controlled trial published in The Lancet Oncology found that Michelson Diagnostics' VivoSight OCT laser scanner can avoid 66% of diagnostic biopsies for basal cell carcinoma (BCC), the most common skin cancer in the UK affecting one in five white people over their lifetime. The study, conducted on 598 patients comparing OCT-guided diagnosis against standard punch biopsy, demonstrated that the technology enables same-day diagnosis and treatment while being non-inferior in accuracy and significantly more cost-effective. The findings represent a major advancement for dermatologists, hospitals, and clinics seeking to reduce the burden on over-pressed NHS histopathology services and eliminate invasive procedures for patients.GlobeNewswirePresentation at the World Congress of DermatologyMichelson Diagnostics will present VivoSight OCT data at the World Congress of Dermatology in Vancouver and Maidstone on June 12, 2015. The study of 164 patients showed diagnosis accuracy rising from 65.8% to 87.4% with OCT. The company plans to expand VivoSight availability in Germany and select European territories.GlobeNewswireMichelson Diagnostics Limited: Launch of Next Generation OCT System, VivoSight DxMichelson Diagnostics launched VivoSight Dx, its second-generation OCT system, at the DDG 2015 congress in Berlin. The lighter, more compact device features a new GUI and targets dermatologists for non-melanoma skin cancer diagnosis, with over 50 clinical publications supporting it.GlobeNewswireLandmark VivoSight OCT Clinical Study Published in British Journal of DermatologyMichelson Diagnostics published full results of a clinical study in the British Journal of Dermatology showing VivoSight OCT improves basal cell carcinoma diagnosis. Specificity rose to 75.3% versus 28.6% for clinical assessment alone, and overall diagnostic accuracy increased from 65.8% to 87.4%.FinSMEsMichelson Diagnostics Raises €2.5M in First Tranche of Series B FundingMichelson Diagnostics raised €2.5M in its first Series B tranche, led by Smith & Nephew with participation from Kent County Council and existing investors. The funds will support German expansion, launch of the VivoSight OCT system, and a US clinical study. A second £1.5M tranche is expected to close in coming months.FinSMEsMichelson Diagnostics Raises £1.98M in Series A2 FinancingMichelson Diagnostics raised £1.98M ($3.25M) in Series A2 financing led by Octopus Investments. The funds will expand VivoSight sales in Germany, develop a second-generation system, and initiate US market access with a planned pilot clinical study.FinSMEsMichelson Diagnostics Receives £300K Second Investment by Octopus InvestmentsMichelson Diagnostics received a £300k second investment from Octopus Investments, adding to its £1.7M initial funding. The company's VivoSight scanner, cleared by CE and FDA, is being evaluated by skin cancer specialists. Funds will support manufacturing and sales growth in the UK and USA.FinSMEsMichelson Diagnostics Raises £1.7M from OctopusMichelson Diagnostics raised £1.7M from Octopus Investments to fund VivoSight scanner manufacturing and sales infrastructure in the UK and USA. The company's laser scanning technology has CE and FDA clearance for non-melanoma skin cancer diagnosis and is being trialled by specialists.GlobeNewswireMichelson Diagnostics VivoSight(TM) OCT Scanner Receives FDA 510(k) ClearanceMichelson Diagnostics received FDA 510(k) clearance for its VivoSight OCT scanner, the first Fourier-domain OCT scanner cleared outside ophthalmology. The device uses multi-beam OCT technology for real-time 2D/3D imaging of external tissues. CEO Jon Holmes said the clearance enables US clinical use and the scanner will be exhibited at SPIE BIOS 2010.GlobeNewswireMichelson Diagnostics Receives New Funding to Accelerate GrowthMichelson Diagnostics raised GBP664,000 to fund growth, including expanding its sales force and trials. The company's VivoSight OCT scanner has medical approval in Europe and a 510(k) submission to the FDA, with approval expected in the first half of 2010.